@article{d77465c8f7a245649aa1e4d6ffd3d6c5,
title = "Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany",
keywords = "DOSING FREQUENCY, MEDICATION ADHERENCE, STROKE RISK, WARFARIN, SAFETY, EFFICACY, RIVAROXABAN, DABIGATRAN, REGIMENS, THERAPY",
author = "E. Smits and F. Andreotti and E. Houben and H.J.G.M. Crijns and S. Haas and G. Spentzouris and T. Schink and R. Gini and C. Bartolini and {Penning-van Beest}, F. and R. Herings",
year = "2022",
month = jun,
doi = "10.1007/s40801-021-00289-w",
language = "English",
volume = "9",
pages = "199--209",
journal = "Drugs-Real World Outcomes",
issn = "2199-1154",
publisher = "Adis International Ltd",
number = "2",
}